| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |